Exelixis (EXEL) Free Cash Flow (2010 - 2026)

Exelixis (EXEL) recorded quarterly Free Cash Flow of $250.3 million in Q2 2026, down 24.68% quarter-over-quarter from $332.4 million in Q1 2026, and up 20.07% on a YoY basis from $208.5 million in Q2 2025.

Exelixis (EXEL) Free Cash Flow (2010 - 2026) Analysis & Trends

Exelixis' Free Cash Flow history runs 17 years deep, the most recent figure standing at $250.3 million for Q2 2026.

  • In Q2 2026, Free Cash Flow rose 20.07% year-over-year to $250.3 million; the TTM figure through Apr 2026 stood at $917.7 million (up 11.79% YoY), while the FY2026 annual figure was $875.8 million, up 30.42% from the prior year.
  • Free Cash Flow was $250.3 million for Q2 2026 at Exelixis, down from $332.4 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $332.4 million in Q1 2026 to a low of -$2.6 million in Q4 2023.
  • Historically, Free Cash Flow has averaged $142.7 million across 5 years, with a median of $113.0 million in 2024.
  • The sharpest annual moves came in 2023 and 2025: Free Cash Flow plunged 104.01% in 2023, then jumped 9315.52% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at $64.0 million in 2022, then slumped by 104.01% to -$2.6 million in 2023, then surged by 10362.91% to $263.1 million in 2024, then climbed by 9.77% to $288.8 million in 2025, then decreased by 13.33% to $250.3 million in 2026.
  • The last three Free Cash Flow figures came in at $250.3 million (Q2 2026), $332.4 million (Q1 2026), and $288.8 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -1.67 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -12.20 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -2.49 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 1.29 Bn
9 Abivax 95.45 Bn 95.45 Bn - 63,220.27
10 Exelixis 13.71 Bn 12.93 Bn 590.86 Mn 250.34 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 250.34 Mn
Apr 3, 2026 250.34 Mn
Jan 2, 2026 332.36 Mn
Jan 2, 2026 332.36 Mn
Oct 3, 2025 288.84 Mn
Oct 3, 2025 288.84 Mn
Jul 4, 2025 46.16 Mn
Jul 4, 2025 46.16 Mn
Apr 4, 2025 208.49 Mn
Apr 4, 2025 208.49 Mn
Jan 3, 2025 236.29 Mn
Jan 3, 2025 236.29 Mn
Sep 27, 2024 263.14 Mn
Sep 27, 2024 263.14 Mn
Jun 28, 2024 112.98 Mn
Jun 28, 2024 112.98 Mn
Mar 29, 2024 59.13 Mn
Mar 29, 2024 59.13 Mn
Dec 29, 2023 -2.56 Mn
Dec 29, 2023 -2.56 Mn